News about Digitalization

Xcell Biosciences and Culture Biosciences Partner to Improve Cell Therapy Quality with AI and ML

Xcell Biosciences and Culture Biosciences Partner to Improve Cell Therapy Quality with AI and ML

Xcell Biosciences has partnered with Culture Biosciences to integrate AI- and ML-driven analytics into cell therapy development. The collaboration leverages a cloud-based platform capable of multivariate analysis, enabling real-time optimisation to enhance cell therapy performance and improve patient outcomes.

Digitalization | 10/12/2025 | By Akanki |  322

FDA Qualifies PathAI's AIM-MASH as First AI Tool for MASH Clinical Trials

FDA Qualifies PathAI's AIM-MASH as First AI Tool for MASH Clinical Trials

PathAI has achieved a regulatory milestone with the FDA qualifying its AIM-MASH AI Assist as the first AI-powered tool for MASH clinical trials. The qualification follows the EMA CHMP’s endorsement earlier this year, reinforcing PathAI’s leadership in advancing AI-driven histopathology solutions across American and European drug-development framework.

Digitalization | 10/12/2025 | By Akanki |  1296

SmartWinnr Launches Medical Simulation to Advance AI Readiness in Pharma and Medtech

SmartWinnr Launches Medical Simulation to Advance AI Readiness in Pharma and Medtech

SmartWinnr has introduced a new medical simulation platform designed to help pharma and medtech companies accelerate AI readiness. Developed in collaboration with life sciences leaders and AI experts, the solution delivers clinically accurate, compliant, and emotionally intelligent training simulations for healthcare professionals.

Digitalization | 03/12/2025 | By Akanki |  359

Verida: Philips unveils first AI-driven detector-based spectral CT

Verida: Philips unveils first AI-driven detector-based spectral CT

The new platform integrates AI across the entire imaging chain—from acquisition to reconstruction—to reduce system noise, enhance image clarity, and significantly accelerate clinical workflows.

Digitalization | 02/12/2025 | By Darshana |  396

Generate:Biomedicines to Begin Phase 3 Trials of AI-Engineered Asthma Antibody GB-0895

Generate:Biomedicines to Begin Phase 3 Trials of AI-Engineered Asthma Antibody GB-0895

Generate:Biomedicines is set to begin its first global Phase 3 trials for GB-0895, an AI-engineered long-acting anti-TSLP antibody for patients with severe, uncontrolled asthma. The SOLAIRIA-1 and SOLAIRIA-2 studies will evaluate the therapy in about 1,600 patients, marking a key milestone for programmable biology in respiratory care.

Digitalization | 02/12/2025 | By Dineshwori |  482

Himalaya Wellness Partners with Unicommerce to Boost Omnichannel Growth

Himalaya Wellness Partners with Unicommerce to Boost Omnichannel Growth

Himalaya Wellness, one of India’s most trusted legacy wellness brands, has partnered with Unicommerce, a leading e-commerce enablement SaaS platform, to streamline its digital operations and accelerate its omnichannel transformation.

Digitalization | 28/11/2025 | By Darshana |  245

Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health

Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health

Merck KGaA has entered into a major strategic collaboration with Valo Health to use Valo’s AI-powered human causal biology platform for discovering and developing new treatments for Parkinson’s disease and related disorders.

Digitalization | 21/11/2025 | By Darshana |  627

Qure.ai Partners with Microsoft to Expand Lung Cancer AI Access in the US

Qure.ai Partners with Microsoft to Expand Lung Cancer AI Access in the US

Qure.ai has partnered with Microsoft to broaden access to its advanced lung cancer detection and management AI suite across the US. The collaboration integrates Qure.ai’s LLM- and agentic AI–driven tools into clinical workflows, helping radiology and pulmonology teams accelerate patient detection, diagnosis, and treatment pathways.

Digitalization | 20/11/2025 | By Dineshwori |  325

Lunit and Labcorp Partner to Advance AI-Driven Digital Pathology Research

Lunit and Labcorp Partner to Advance AI-Driven Digital Pathology Research

Lunit and Labcorp have collaborated to accelerate innovation in Artificial Intelligence (AI)-driven digital pathology, combining Labcorp’s clinical and pathology expertise with Lunit’s advanced AI technologies to enhance tumour microenvironment analysis and support next-generation oncology research.

Digitalization | 20/11/2025 | By Dineshwori |  283

GSK, Fleming Initiative Launch AI-Driven Grand Challenges to Target AMR

GSK, Fleming Initiative Launch AI-Driven Grand Challenges to Target AMR

These initiatives bring together leading scientific expertise and advanced technologies—including AI—to tackle urgent gaps in antibiotic discovery, fungal infection treatment, immune response understanding, disease prediction, clinical prescribing, and global policy engagement.

Digitalization | 19/11/2025 | By Darshana |  227

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members